Blue Trust’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
Blue Trust's CNMD Position: Q3 2026 in Review
Blue Trust reduced its CONMED (CNMD) stake by 6.9% in Q3 2026, selling an estimated $20.9K and leaving 6,140 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #657.
Blue Trust first reported a position in CNMD in Q3 2022 and has held it in 17 quarters since. The position peaked at $310K in Q1 2025. 215 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.
- Blue Trust held 6,140 shares of CONMED worth $284K as of Q3 2026.
- Blue Trust sold 456 CONMED shares in Q3 2026, an estimated $20.9K.
- CONMED made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #657 holding.
- Blue Trust first reported a position in CONMED in Q3 2022 and has held it in 17 quarters since.
- Blue Trust's CONMED position peaked at $310K in Q1 2025.
- 215 funds tracked by Wall St. Rank held CONMED as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.